ArticleMolecules (Basel, Switzerland)2023

Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug for the Treatment of Ovarian and Breast Cancer.

Ibrahim A Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.